Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$56.06 - $74.11 $2.33 Million - $3.09 Million
-41,642 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$60.19 - $97.37 $2.51 Million - $4.05 Million
41,642 New
41,642 $3.11 Million
Q2 2021

Aug 13, 2021

SELL
$43.76 - $53.11 $367,584 - $446,124
-8,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$41.69 - $54.95 $368,164 - $485,263
-8,831 Reduced 51.25%
8,400 $414,000
Q4 2020

Feb 12, 2021

BUY
$41.16 - $47.47 $503,427 - $580,605
12,231 Added 244.62%
17,231 $725,000
Q3 2020

Nov 12, 2020

BUY
$43.36 - $53.53 $216,800 - $267,650
5,000 New
5,000 $229,000
Q1 2020

May 15, 2020

SELL
$40.22 - $62.0 $321,760 - $496,000
-8,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$57.95 - $66.61 $463,600 - $532,880
8,000 New
8,000 $494,000
Q1 2019

May 15, 2019

SELL
$69.08 - $105.66 $469,744 - $718,488
-6,800 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$65.41 - $84.65 $444,788 - $575,620
6,800 New
6,800 $482,000
Q2 2018

Aug 14, 2018

SELL
$81.85 - $120.51 $4.15 Million - $6.11 Million
-50,694 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$57.91 - $92.15 $1.76 Million - $2.8 Million
30,404 Added 149.85%
50,694 $4.1 Million
Q4 2017

Feb 09, 2018

BUY
$45.65 - $59.37 $926,238 - $1.2 Million
20,290
20,290 $1.19 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $177M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.